NEA Management Company’s Rigel Pharmaceuticals RIGL Stock Holding History

NEA Management Company’s Portfolio RIGL Stock Details RIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-324,315	Closed	-$5.93M	–	55
2020 Q2	$5.93M	Hold	324,315	–	–	0.24%	37
2020 Q1	$5.06M	Hold	324,315	–	–	0.26%	38
2019 Q4	$6.94M	Hold	324,315	–	–	0.33%	36
2019 Q3	$6.07M	Hold	324,315	–	–	0.5%	30
2019 Q2	$8.46M	Hold	324,315	–	–	0.59%	30
2019 Q1	$8.34M	Hold	324,315	–	–	0.43%	32
2018 Q4	$7.46M	Hold	324,315	–	–	0.3%	33
2018 Q3	$10.4M	Hold	324,315	–	–	0.45%	34
2018 Q2	$9.18M	Hold	324,315	–	–	0.43%	32
2018 Q1	$11.5M	Hold	324,315	–	–	0.51%	27
2017 Q4	$12.6M	Hold	324,315	–	–	0.52%	28
2017 Q3	$8.24M	Hold	324,315	–	–	0.29%	31
2017 Q2	$8.85M	Hold	324,315	–	–	0.32%	26
2017 Q1	$10.4M	Hold	324,315	–	–	0.36%	23
2016 Q4	$7.72M	Hold	324,315	–	–	0.31%	24
2016 Q3	$11.9M	Hold	324,315	–	–	0.53%	21
2016 Q2	$7.23M	Hold	324,315	–	–	0.38%	25
2016 Q1	$6.75M	Hold	324,315	–	–	0.45%	25
2015 Q4	$9.83M	Hold	324,315	–	–	0.63%	20
2015 Q3	$8.01M	Hold	324,315	–	–	0.53%	23
2015 Q2	$10.4M	Hold	324,315	–	–	0.54%	26
2015 Q1	$11.6M	Hold	324,315	–	–	0.52%	26
2014 Q4	$7.36M	Hold	324,315	–	–	0.36%	30
2014 Q3	$6.29M	Hold	324,315	–	–	0.32%	30
2014 Q2	$11.8M	Hold	324,315	–	–	0.55%	26
2014 Q1	$12.6M	Hold	324,315	–	–	0.62%	22
2013 Q4	$9.24M	Hold	324,315	–	–	0.45%	24
2013 Q3	$11.6M	Hold	324,315	–	–	0.46%	25
2013 Q2	$10.8M	Buy	+324,315	New	+$14.7M	0.48%	24

Other funds holding RIGL

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

NEA Management Company's RIGL Position: Q3 2020 in Review

NEA Management Company sold out of Rigel Pharmaceuticals (RIGL) in Q3 2020, closing a stake of 324,315 shares — an estimated $5.93M sold.

NEA Management Company first reported a position in RIGL in Q2 2013 and held it in 29 quarters. The position peaked at $12.6M in Q4 2017. 138 funds tracked by Wall St. Rank hold RIGL as of Q3 2020.

NEA Management Company reported no remaining Rigel Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
NEA Management Company sold 324,315 Rigel Pharmaceuticals shares in Q3 2020, an estimated $5.93M.
NEA Management Company first reported a position in Rigel Pharmaceuticals in Q2 2013 and held it in 29 quarters.
NEA Management Company's Rigel Pharmaceuticals position peaked at $12.6M in Q4 2017.
138 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q3 2020.

Based on NEA Management Company's 13F filing for Q3 2020, filed 6 Nov 2020.